Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Hill Inc V.HILL

Alternate Symbol(s):  HSEEF

Hill Incorporated is a progressive bioscience implementation company. It is engaged in building pathways to better and healthier living by leveraging its consumer-packaged goods (CPG) expertise to commercialize technologies to craft cannabis solutions and non-alcoholic beverage products globally. Its Hill Avenue Cannabis business unit is pioneering the space where craft consumer products meet bioscience by combining its CPG commercialization expertise with its rights to use Lexaria Bioscience Corp’s DehydraTECH patent portfolio for product development, licensing and business-to-business (B2B) and business-to-consumer sales of cannabis ingredients or products on a global scale. Its Hill Street Beverages business unit represents its legacy alcohol-free consumer beverage marketing and distribution business. It provides DehydraTECH-enabled B2B solutions for both cannabis extractors and ingredient suppliers and CPG manufacturers whose products are infused with cannabis and or hemp extracts.


TSXV:HILL - Post by User

Bullboard Posts
Post by roatan2on Sep 28, 2018 12:30pm
64 Views
Post# 28710114

Future of cannabis is in products, Canopy CEO says

Future of cannabis is in products, Canopy CEO sayshttps://www.cnbc.com/2018/06/28/from-sleep-aids-to-beverages-the-future-of-cannabis-is-in-products-c.html

Canada's largest medical marijuana producer, Canopy Growth, took a hit after its first earnings report as a public company in the U.S. stoked fears Canadian marijuana is overvalued, but CEO Bruce Linton shrugged off investor concerns on Thursday. He said the company focused more on cannabis as a product, than cannabis as a commodity.

In Canada, "by 2020 or 2021, there will be too much cannabis produced. If I'm still selling primarily an ingredient, I have completely dropped the ball. You want to transform it," Linton said on CNBC's "Squawk Alley."

As Canada marches toward recreational legalization in October, two of the marijuana-based products Linton is most optimistic about marketing to a broader audience are beverages and sleep aids.

Bullboard Posts